- Is It Ethical to Use Enhancement Technologies to Make Us Better than Well?

  • President's Council on Bioethics. Beyond therapy: Biotechnology and the pursuit of happiness. New York: Dana Press; 2003. 400 pp.
  • McKibben, W. Enough: Staying human in an engineered age. New York: Times Books; 2003. 271 pp.
  • Callahan, D. What price better health? Hazards of the research imperative. Berkeley: University of California Press; 2003. 329 pp.
  • Elliott, C. Better than well: American medicine meets the American dream. New York: W. W. Norton; 2003. 357 pp.
  • Fukuyama, F. Our posthuman future: Consequences of the biotechnology revolution. New York: Picador; 2003. 272 pp.
  • Rothman, S.; Rothman, D. The pursuit of perfection: The promise and perils of medical enhancement. New York: Pantheon Books; 2003. 292 pp.
  • Kass, LR. Life, liberty, and the defense of dignity: The challenge for bioethics. San Francisco: Encounter Books; 2002. 313 pp.
  • Kristol, W.; Cohen, E. The future is now: America confronts the new genetics. Lanham (Maryland): Rowman and Littlefield; 2002. 357 pp.
  • Sandel S. The case against perfection. Atlantic Monthly. 2004 Apr;:51–62.
  • Isaacson, W. Benjamin Franklin: An American life. New York: Simon and Schuster; 2003. 590 pp.
  • Whorton, J. Crusaders for fitness: The history of American health reformers. Princeton (New Jersey): Princeton University Press; 1984. 359 pp.
  • Caplan AL. Is biomedical research too dangerous to pursue? Science. 2004;303:1142. 
  • Peers EA. , translator. Saint Teresa of Avila. The way of perfection. Garden City, New York: Image Books; 1964. 320 pp.
  • Pinker, S. The blank slate: The modern denial of human nature. New York: Viking; 2002. 509 pp.
  • Tenner, E. Our own devices: The past and future of body technology. New York: Alfred A. Knopf; 2003. 314 pp.
  • Moynihan R. Drug firms hype disease as sales ploy, industry chief claims. BMJ. 2002;324:867. 
  • Mundy, A. Dispensing with the truth: The victims, the drug companies, and the dramatic story behind the battle over Fen-Phen. New York: St. Martin's Press; 2001. 402 pp.
  • Barrett A. Wyeth: The class action that wouldn't quit. Business Week. 2004 May 24;:88.
  • Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333. 
  • Whittington C, Kendall T, Fonagy P, Cottrell D, Cotgrove A, et al. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet. 2004;363:1341–1344. 
  • Kassirer, J. On the take: How medicine's complicity with big business can endanger your health. New York: Oxford University Press; 2004. 251 pp.
  • Moynihan R, Heath I, Henry D. Selling sickness: The pharmaceutical industry and disease mongering. BMJ. 2002;324:886–891. 
  • Greider, K. The big fix: How the pharmaceutical industry rips off American consumers. New York: Public Affairs; 2003. 189 pp.
  • Angell, M. The truth about the drug companies: How they deceive us and what to do about it. New York: Random House; 2004. 305 pp.
  • Elliott C. Pharma buys a conscience. Am Prospect. 2004;12(17):16–20.

rating: 1.00 from 1 votes | updated on: 15 Nov 2006 | views: 5663 |

Rate article:

excellent! bad…